MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-12-2026
Aethlon Medical EV - Enterprise Value 2011-2026 | AEMD
Annual EV - Enterprise Value Aethlon Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -237 K | -2.78 M | -11.2 M | -8.45 M | 3.6 M | -3.71 M | 11.8 M | 10.8 M | 16.9 M | 34.9 M | 45.5 M | 55.9 M | 25.9 M | 21.2 M | 12.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 55.9 M | -11.2 M | 14.2 M |
EV - Enterprise Value of other stocks in the Medical devices industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
15.2 B | $ 187.53 | 0.54 % | $ 14 B |  USA |
 |
Axonics Modulation Technologies
AXNX
|
2.67 B | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-1.67 M | - | 1.37 % | $ 20.5 M | USA |
 |
Bio-Rad Laboratories
BIO
|
10.1 B | $ 291.34 | -1.6 % | $ 8.22 B | USA |
 |
BioSig Technologies
BSGM
|
33.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Bruker Corporation
BRKR
|
3.81 B | $ 39.12 | -0.91 % | $ 5.83 K | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
76.6 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
40.9 M | - | -26.83 % | $ 2.62 M | USA |
 |
Conformis
CFMS
|
3.84 M | - | - | $ 16.4 M | USA |
 |
Avinger
AVGR
|
17.3 M | - | -20.74 % | $ 369 K | USA |
 |
AdaptHealth Corp.
AHCO
|
3.89 B | $ 12.48 | -1.34 % | $ 1.69 B | USA |
 |
Allied Healthcare Products
AHPI
|
696 K | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
655 M | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
-5.83 M | - | -5.86 % | $ 30.6 M | USA |
 |
Cytosorbents Corporation
CTSO
|
66.9 M | $ 0.61 | 3.18 % | $ 38 M | USA |
 |
EDAP TMS S.A.
EDAP
|
139 M | $ 3.55 | 0.85 % | $ 133 M |  France |
 |
Boston Scientific Corporation
BSX
|
111 B | $ 64.77 | 0.26 % | $ 95.9 B | USA |
 |
Apollo Endosurgery
APEN
|
423 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
595 M | - | 0.15 % | $ 844 M | USA |
 |
Eargo
EAR
|
-53 M | - | - | $ 10.2 M | USA |
 |
ClearPoint Neuro
CLPT
|
340 M | $ 10.46 | - | $ 296 M | USA |
 |
Dynatronics Corporation
DYNT
|
13.8 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
170 M | $ 25.88 | 0.66 % | $ 219 M | USA |
 |
Second Sight Medical Products
EYES
|
7.43 M | - | -0.97 % | $ 54.4 M | USA |
 |
CryoLife, Inc.
CRY
|
70.4 M | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-7.7 M | - | 1.15 % | $ 34.5 M | USA |
 |
Soliton, Inc.
SOLY
|
-100 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.54 B | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
6.89 M | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
427 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
-1.79 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
639 M | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
579 M | $ 17.49 | -2.04 % | $ 410 M | USA |
 |
Globus Medical
GMED
|
12.7 B | $ 93.94 | -0.62 % | $ 12.7 B | USA |
 |
Helius Medical Technologies
HSDT
|
3.7 M | $ 1.92 | -1.03 % | $ 1.17 M | USA |
 |
Butterfly Network
BFLY
|
765 M | $ 5.04 | 3.6 % | $ 1.07 B | USA |
 |
Intersect ENT, Inc.
XENT
|
1.02 B | - | - | $ 955 M | USA |
 |
Inogen
INGN
|
163 M | $ 6.2 | - | $ 165 M | USA |
 |
IRIDEX Corporation
IRIX
|
34.8 M | $ 1.02 | -1.92 % | $ 17.3 M | USA |
 |
LENSAR
LNSR
|
142 M | $ 6.22 | -0.56 % | $ 74.4 M | USA |
 |
BIOLASE
BIOL
|
26.8 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
295 M | $ 10.76 | -2.09 % | $ 385 M | USA |
 |
Inspire Medical Systems
INSP
|
1.78 B | $ 56.25 | -0.72 % | $ 1.65 B | USA |
 |
CONMED Corporation
CNMD
|
2.57 B | $ 39.15 | -0.79 % | $ 1.22 B | USA |
 |
LivaNova PLC
LIVN
|
4.58 B | $ 65.23 | 0.14 % | $ 3.56 B |  Britain |
 |
Integer Holdings Corporation
ITGR
|
4.62 B | $ 87.02 | -0.9 % | $ 3.02 B | USA |
 |
FONAR Corporation
FONR
|
91.5 M | $ 18.8 | 0.16 % | $ 123 M | USA |
 |
Invacare Corporation
IVC
|
-34.7 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
49.3 B | $ 77.81 | -0.49 % | $ 45.5 B | USA |
 |
Penumbra
PEN
|
13.4 B | $ 332.81 | 0.12 % | $ 13 B | USA |